Prenatal exposure to drugs, including both prescription and recreational drugs, can have a significant effect on the health of both the mother and the unborn baby. According to the Centers for Disease Control and Prevention (CDC), any type of drug use during pregnancy can increase the risk for birth defects, preterm birth, low birth weight, and other health problems for the baby. The effects of drug use during pregnancy depend on the type of drug used and the amount used. For example, the use of certain prescription drugs such as opioids, benzodiazepines, and certain antidepressants can increase the risk of preterm labor, low birth weight, and other adverse effects. The use of recreational drugs such as marijuana, cocaine, and alcohol can also cause serious health problems for the unborn baby, including birth defects, developmental delays, and physical and behavioral problems. It is important for women to talk to their healthcare provider about any drug use before and during pregnancy. Women should discuss any over-the-counter and prescription medications they are taking, as well as any recreational drugs they are using. Pregnant women should never take any medications, including over-the-counter medications, without first consulting their healthcare provider. It is also important to avoid recreational drug use during pregnancy. Women should also be aware that certain types of drugs can remain in the body for long periods of time, and can still pose a risk to the unborn baby even after the drug has been discontinued. It is important for women to be honest with their healthcare provider about their drug use so that they can receive appropriate medical care and advice.
Title : Pathologic findings in women with atypical glandular cells on Pap test
Neda Zarrin Khameh, Baylor College of Medicine, United States
Title : Application of thread technology in aesthetic and functional gynecology
Marlen Sulamanidze, Total Charm Clinic, Georgia
Title : Exploitation of sperm agglutination factor derived from Staphylococcus aureus as a putative candidate for vaginal contraception
Vijay Prabha, Panjab University, India
Title : Pregnancy outcome after uterine artery embolization for uterine adenomyosis: A systematic review and meta-analysis
Mohamed M Hosni, London North West University Healthcare NHS Trust, United Kingdom
Title : Endometrial functions in recurrent pregnancy loss
Nicoletta Di Simone, Humanitas University Milan, Italy
Title : The dawn of biological restoration in female pelvic floor and vulvovaginal disorders
Irene Eirini Orfanoudaki, University Hospital, Greece